Elite in Subacute Sclerosing Panencephalitis

Dr. Rajesh K. Singh

Internal Medicine | Hospital Medicine
Physician Specialists Of St Lukes LLC
232 S Woods Mill Rd, 
Chesterfield, MO 
Accepting New Patients
16 Years of Experience
Elite in Subacute Sclerosing Panencephalitis
Physician Specialists Of St Lukes LLC
232 S Woods Mill Rd, 
Chesterfield, MO 
OverviewInsuranceLocationsClinical Research

Overview

Rajesh Singh is a Hospital Medicine provider in Chesterfield, Missouri. Dr. Singh has been practicing medicine for over 16 years and is rated as an Elite provider by MediFind in the treatment of Subacute Sclerosing Panencephalitis. His top areas of expertise are Subacute Sclerosing Panencephalitis, Pycnodysostosis, MYH9 Related Thrombocytopenia, Endoscopy, and Ureteroscopy. Dr. Singh is currently accepting new patients.

His clinical research consists of co-authoring 338 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Subacute Sclerosing Panencephalitis.

Graduate Year
2009
Specialties
Internal Medicine
Hospital Medicine
Licenses
Internal Medicine in MO
Hospital Affiliations
Mercy Hospital South
Mercy Hospital Jefferson
St Lukes Hospital
Languages Spoken
English
Hindi
Spanish
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Essence Healthcare
  • INSURANCE PLAN
  • MEDICARE MAPD
Health Alliance
  • EPO
  • HMO
  • POS
  • PPO
Home State Health
  • EPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 8 Less Insurance Carriers -

Locations

PHYSICIAN SPECIALISTS OF ST LUKES LLC
232 S Woods Mill Rd, Chesterfield, MO 63017

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 1b/2 Open-Label Study With Randomization in Phase 2 of IMU-131 HER2/Neu Peptide Vaccine Plus Standard of Care Chemotherapy in Patients With HER2/Neu Overexpressing Metastatic or Advanced Adenocarcinoma of the Stomach or Gastroesophageal Junction
A Phase 1b/2 Open-Label Study With Randomization in Phase 2 of IMU-131 HER2/Neu Peptide Vaccine Plus Standard of Care Chemotherapy in Patients With HER2/Neu Overexpressing Metastatic or Advanced Adenocarcinoma of the Stomach or Gastroesophageal Junction
Enrollment Status: Completed
Publish Date: April 16, 2025
Intervention Type: Biological, Drug
Study Drugs: IMU-131, Cisplatin and either Fluorouracil (5-FU) or Capecitabine or Oxaliplatin and capecitabine
Study Phase: Phase 1/Phase 2
A Single-Arm, Phase 4 Study of Abemaciclib, a CDK4 and CDK6 Inhibitor, in Combination With Endocrine Therapy (Anastrozole/Letrozole or Fulvestrant) in Participants With Hormone Receptor Positive, Human Epidermal Growth Factor Receptor 2 Negative Locally Advanced and/or Metastatic Breast Cancer in India
A Single-Arm, Phase 4 Study of Abemaciclib, a CDK4 and CDK6 Inhibitor, in Combination With Endocrine Therapy (Anastrozole/Letrozole or Fulvestrant) in Participants With Hormone Receptor Positive, Human Epidermal Growth Factor Receptor 2 Negative Locally Advanced and/or Metastatic Breast Cancer in India
Enrollment Status: Completed
Publish Date: November 24, 2023
Intervention Type: Drug
Study Drugs: Abemaciclib, Nonsteroidal Aromatase Inhibitor, Fulvestrant
Study Phase: Phase 4
View 1 Less Clinical Trial

338 Total Publications

Acute Hemorrhagic Leukoencephalitis With Active Hepatitis B Virus Infection: A Case Report.
Acute Hemorrhagic Leukoencephalitis With Active Hepatitis B Virus Infection: A Case Report.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: October 08, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Singh's expertise for a condition
ConditionClose
      View All 12 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile